Literature DB >> 15184424

Multilocus sequence typing is a reliable alternative method to DNA fingerprinting for discriminating among strains of Candida albicans.

Juan C Robles1, Larry Koreen, Steven Park, David S Perlin.   

Abstract

Multilocus sequence typing (MLST) has emerged as a powerful new DNA-typing tool for the evaluation of intraspecies genetic relatedness. This method relies on DNA sequence analysis of nucleotide polymorphisms in housekeeping genes and has shown a high degree of intraspecies discriminatory power for bacterial and fungal pathogens. However, the results of the MLST scheme for Candida albicans have heretofore never been formally compared to those of other established typing techniques. To assess the value of MLST relative to those of other DNA fingerprinting tools for discriminating among strains of C. albicans, we applied it to a previously well-characterized set of 29 C. albicans isolates evaluated by the random amplified polymorphic DNA (RAPD), multilocus enzyme electrophoresis (MLEE), and Ca3 Southern hybridization probe techniques. MLST identified three clusters of genetically related isolates, with 82.3% direct concordance with MLEE, 82.7% with RAPD analysis, and 86.2% with the Ca3 Southern hybridization technique. When MLST was applied to a subset of 22 isolates of unrelated origins, it identified 21 independent diploid sequence types (DSTs), resulting in a discriminatory power of 99.6%. These DSTs were 96.9, 99.6, and 99.6% concordant with the genotypes identified by RAPD analysis, MLEE, and Ca3 Southern hybridization, respectively. These results demonstrate that MLST is a highly effective technique that performs at least comparably to other established DNA fingerprinting techniques.

Entities:  

Mesh:

Year:  2004        PMID: 15184424      PMCID: PMC427821          DOI: 10.1128/JCM.42.6.2480-2488.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  The IS1167 insertion sequence is a phylogenetically informative marker among isolates of serotype 6B Streptococcus pneumoniae.

Authors:  D A Robinson; S K Hollingshead; J M Musser; A J Parkinson; D E Briles; M J Crain
Journal:  J Mol Evol       Date:  1998-08       Impact factor: 2.395

2.  Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998.

Authors:  M A Pfaller; R N Jones; G V Doern; H S Sader; S A Messer; A Houston; S Coffman; R J Hollis
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

3.  Identification and phylogenetic relationship of the most common pathogenic Candida species inferred from mitochondrial cytochrome b gene sequences.

Authors:  K Yokoyama; S K Biswas; M Miyaji; K Nishimura
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

4.  Prospective study of Candida species in patients at a comprehensive cancer center.

Authors:  A Safdar; V Chaturvedi; E W Cross; S Park; E M Bernard; D Armstrong; D S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

5.  The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  Mark C Enright; D Ashley Robinson; Gaynor Randle; Edward J Feil; Hajo Grundmann; Brian G Spratt
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

6.  International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program.

Authors:  M A Pfaller; D J Diekema; R N Jones; H S Sader; A C Fluit; R J Hollis; S A Messer
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

7.  Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study.

Authors:  D J Diekema; S A Messer; A B Brueggemann; S L Coffman; G V Doern; L A Herwaldt; M A Pfaller
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

8.  Usefulness of multilocus sequence typing for characterization of clinical isolates of Candida albicans.

Authors:  M-E Bougnoux; S Morand; C d'Enfert
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

9.  Typing of Candida albicans isolates by sequence analysis of the cytochrome b gene and differentiation from Candida stellatoidea.

Authors:  S K Biswas; K Yokoyama; L Wang; K Nishimura; M Miyaji
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

10.  Nosocomial Candida albicans acquisition in a geriatric unit: epidemiology and evidence for person-to-person transmission.

Authors:  S Fanello; J P Bouchara; N Jousset; V Delbos; A M LeFlohic
Journal:  J Hosp Infect       Date:  2001-01       Impact factor: 3.926

View more
  25 in total

1.  Multilocus sequence typing for analyses of clonality of Candida albicans strains in Taiwan.

Authors:  Kuo-Wei Chen; Yee-Chun Chen; Hsiu-Jung Lo; Frank C Odds; Tzu-Hui Wang; Chi-Yang Lin; Shu-Ying Li
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

Review 2.  Multilocus sequence typing: Data analysis in clinical microbiology and public health.

Authors:  Christopher B Sullivan; Matthew A Diggle; Stuart C Clarke
Journal:  Mol Biotechnol       Date:  2005-03       Impact factor: 2.695

3.  Four-year persistence of a single Candida albicans genotype causing bloodstream infections in a surgical ward proven by multilocus sequence typing.

Authors:  Maria Anna Viviani; Massimo Cogliati; Maria Carmela Esposto; Anna Prigitano; Anna Maria Tortorano
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

Review 4.  Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects.

Authors:  Nongnuch Vanittanakom; Chester R Cooper; Matthew C Fisher; Thira Sirisanthana
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

5.  Comparative sequencing of the serine-aspartate repeat-encoding region of the clumping factor B gene (clfB) for resolution within clonal groups of Staphylococcus aureus.

Authors:  Larry Koreen; Srinivas V Ramaswamy; Steven Naidich; Irina V Koreen; Gavin R Graff; Edward A Graviss; Barry N Kreiswirth
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

6.  Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates.

Authors:  S Park; R Kelly; J Nielsen Kahn; J Robles; M-J Hsu; E Register; W Li; V Vyas; H Fan; G Abruzzo; A Flattery; C Gill; G Chrebet; S A Parent; M Kurtz; H Teppler; C M Douglas; D S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

7.  Comparison of microsatellite length polymorphism and multilocus sequence typing for DNA-Based typing of Candida albicans.

Authors:  Dea Garcia-Hermoso; Odile Cabaret; Gael Lecellier; Marie Desnos-Ollivier; Damien Hoinard; Dorothée Raoux; Jean-Marc Costa; Françoise Dromer; Stéphane Bretagne
Journal:  J Clin Microbiol       Date:  2007-10-10       Impact factor: 5.948

8.  Mating is rare within as well as between clades of the human pathogen Candida albicans.

Authors:  Marie-Elisabeth Bougnoux; Claude Pujol; Dorothée Diogo; Christiane Bouchier; David R Soll; Christophe d'Enfert
Journal:  Fungal Genet Biol       Date:  2007-10-23       Impact factor: 3.495

9.  MP1 homologue-based multilocus sequence system for typing the pathogenic fungus Penicillium marneffei: a novel approach using lineage-specific genes.

Authors:  Patrick C Y Woo; Candy C Y Lau; Ken T K Chong; Herman Tse; Dominic N C Tsang; Rodney A Lee; Cindy W S Tse; Tak-Lun Que; Liliane M W Chung; Antonio H Y Ngan; Wai-Ting Hui; Samson S Y Wong; Susanna K P Lau; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2007-09-19       Impact factor: 5.948

10.  PCR melting profile (PCR MP)--a new tool for differentiation of Candida albicans strains.

Authors:  Beata Krawczyk; Justyna Leibner-Ciszak; Anna Mielech; Magdalena Nowak; Józef Kur
Journal:  BMC Infect Dis       Date:  2009-11-11       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.